Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001655759-25-000085
Filing Date
2025-05-01
Accepted
2025-05-01 17:16:13
Documents
84
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-20250331.htm   iXBRL 10-Q 902411
2 EX-31.1 arvn-20250331x10qex311.htm EX-31.1 10287
3 EX-31.2 arvn-20250331x10qex312.htm EX-31.2 10448
4 EX-32.1 arvn-20250331x10qex321.htm EX-32.1 5015
5 EX-32.2 arvn-20250331x10qex322.htm EX-32.2 4843
11 arvn-20250331_g1.jpg GRAPHIC 132386
12 arvn-20250331_g2.jpg GRAPHIC 2570
13 arvn-20250331_g3.jpg GRAPHIC 87269
  Complete submission text file 0001655759-25-000085.txt   6692039

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250331.xsd EX-101.SCH 55287
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arvn-20250331_cal.xml EX-101.CAL 63585
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arvn-20250331_def.xml EX-101.DEF 208404
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250331_lab.xml EX-101.LAB 650539
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250331_pre.xml EX-101.PRE 435165
87 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250331_htm.xml XML 681751
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 25904370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)